Using Black Box Warnings to prevent adverse drug events.

Anyone who has been exposed to electronic order entry has experienced the dreaded "alert fatigue". If the goal of electronic prescribing is to improve patient safety and outcomes, alerting clinicians to potential drug interactions or other dosing precautions is necessary. In our current information age, there is a plethora of information available regarding medication safety and potential safety issues with the use of medications. In an attempt to help clinicians sift through all this information, the FDA has established the use of a "Black Box Warning" to call attention to the most important safety issues. A recent study published in the Archives of Internal Medicine reviewed several drug information providers comparing their ability to identify black box warnings and confirmed that Lexicomp is the leader in this area.

In an effort to incorporate this valuable information into the clinician's busy workflow, Lexcomp has recently enhanced their Lexi-Data product to include Black Box Warnings. The Black Box Warnings table allows system vendors to present critical medication safety information from these warnings within a health information system. The data is also structured in a way that will allow the system vendors to filter which alerts are presented, allowing for instance a prescriber to see warning specific to the ordering process and a pharmacist seeing warnings more relevant to the dispensing process.

Improving patient safety requires the use of "intelligent alerting", Lexi-Data has given system vendors the ability to present critical safety information in a meaningful way.

Comments for Using Black Box Warnings to prevent adverse drug events.

Monday, October 24, 2011 by David:: Good post Chris. I am guessing that one of these EMR companies will get on board with the Lexi-Data Black Box warning decisioning tool and include it in their product. It's like a microwave. Few people realized how great they were until they used one.